Pharmacokinetics of Lekethromycin in Swine Following Intramuscular Administration at Different Doses with a Single Intravenous Reference Dose for Absolute Bioavailability and Matrix Comparison
Veterinary Sciences · 20.03.2026 · 13 (3) · 294
DOI: 10.3390/vetsci13030294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 20.03.2026. Verfasst von Qinyao Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Technology Innovation Center for Food Safety Surveillance and Detection (Hainan), Sanya Institute of China Agricultural University, Sanya 572025, Chi…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Lekethromycin (LKMS) is a novel macrolide veterinary antimicrobial. Its propensity for intracellular accumulation causes discrepancies between whole blood and plasma concentrations, complicating pharmacokinetic evaluations. This study compared the pharmacokinetic characteristics, dose proportionality, and bioavailability of LKMS in whole blood and plasma following intramuscular administration in pigs. Forty-two healthy pigs received LKMS via a single intravenous reference dose (5 mg/kg) for absolute bioavailability estimation or intramuscular (1, 2.5, 5, and 10 mg/kg) injection. Pharmacokinetic parameters were calculated using non-compartmental analysis, and dose proportionality was evaluated via a power model. LKMS exhibited rapid absorption and slow elimination, with a plasma half-life of 49.25 to 67.63 h. Whole blood exposure and peak concentrations were 1.5 to 3 times higher than in plasma, indicating extensive blood cell partitioning. As the intramuscular dose increased, the whole blood-to-plasma concentration ratio decreased from 2.83 to 1.15, suggesting a saturable cell uptake mechanism. Consequently, LKMS exhibited non-linear pharmacokinetics in whole blood but demonstrated linear, dose-proportional pharmacokinetics in plasma. Absolute bioavailability based on plasma ranged from 83.2% to 119.5%. Due to saturable blood cell binding, plasma is the optimal matrix for accurately evaluating LKMS systemic exposure and bioavailability in swine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Technology Innovation Center for Food Safety Surveillance and Detection (Hainan), Sanya Institute of China Agricultural University, Sanya 572025, China.
- National Key Laboratory of Detection for Veterinary Drug Residues and Illegal Additives, Ministry of Agriculture and Rural Affairs of the People's Republic of China, Beijing 100193, China.
- Henan Pulike Biological Engineering Co., Ltd., Luoyang 471000, China.
ORCID-Profile: Zeyu Wen, Xingyuan Cao
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Wu, Q., Wen, Z., Meng, J., Yu, R., Xu, N., Zhang, L., Zhou, D., & Cao, X. (2026). Pharmacokinetics of Lekethromycin in Swine Following Intramuscular Administration at Different Doses with a Single Intravenous Reference Dose for Absolute Bioavailability and Matrix Comparison. Veterinary Sciences, 13(3), 294. https://doi.org/10.3390/vetsci13030294
Vancouver
Wu Q, Wen Z, Meng J, Yu R, Xu N, Zhang L, et al. Pharmacokinetics of Lekethromycin in Swine Following Intramuscular Administration at Different Doses with a Single Intravenous Reference Dose for Absolute Bioavailability and Matrix Comparison. Veterinary Sciences. 2026;13(3):294. doi:10.3390/vetsci13030294
BibTeX
@article{Wu2026,
author = {Wu, Qinyao and Wen, Zeyu and Meng, Jinyan and Yu, Runlin and Xu, Nuoyu and Zhang, Lu and Zhou, Degang and Cao, Xingyuan},
title = {Pharmacokinetics of Lekethromycin in Swine Following Intramuscular Administration at Different Doses with a Single Intravenous Reference Dose for Absolute Bioavailability and Matrix Comparison},
journal = {Veterinary Sciences},
year = {2026},
volume = {13},
number = {3},
pages = {294},
doi = {10.3390/vetsci13030294}
}
EUVIMED